Gliclazide terecht eerste keus SU-derivaat voor de behandeling van type 2 diabetes mellitus?

Translated title of the contribution: Is gliclazide rightly the first choice SU-derivative for the treatment of type 2 diabetes mellitus?

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Translated title of the contribution	Is gliclazide rightly the first choice SU-derivative for the treatment of type 2 diabetes mellitus?
Original language	Dutch
Journal	Nederlands Tijdschrift voor Geneeskunde
Issue number	27
Publication status	Published - 1 Jan 2014

Cite this

@article{0553355e6b4d4fda90f9381c772f588a,

title = "Gliclazide terecht eerste keus SU-derivaat voor de behandeling van type 2 diabetes mellitus?",

author = "Abel Thijs",

year = "2014",

month = jan,

day = "1",

language = "Dutch",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",